2상모집 중

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

연구 개요

This study is designed to find out how effective and safe a new drug, GSK3862995B, is for adult participants with bronchiectasis, a chronic lung disease. The study will also test how the body processes the drug and to check for any immune reactions. Participants will be divided into groups randomly to receive either one of two different doses of the study drug or a placebo. The main goal of the study is to see how well the drug works compared to the placebo in helping those with bronchiectasis.

스폰서
리드: GSK
적응증
Bronchiectasis
중재
GSK3862995B, Placebo
목표 등록
446
시작일
2025-10-30
완료(예정)
2027-12-10

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.